Company news

GRI Bio, Inc. news in 2024

GRI Bio, Inc.'s news releases, calls and decks from 2024, newest first.

View company

GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI 0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis Form 8 K

November 14, 2024

GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024 Form 8 K

October 24, 2024

GRI Bio Announces Exercise of Warrants Form 8 K

October 20, 2024

Decks in 2024